Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DCA114273: A Study Comparing Denosumab With Zoledronic Acid in Subjects of Asian Ancestry With Bone Metastases From Solid Tumors

NCT01920568 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01920568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01920568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DCA114273: A Study Comparing Denosumab With Zoledronic Acid in Subjects of Asian Ancestry With Bone Metastases From Solid Tumors
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2013
Completion date
April 30, 2016
Enrollment
487 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

fractures, bone